NCR2 and chronic myelogenous leukemia, BCR-ABL1 positive: In spite of the very low or absent expression of natural cytotoxic receptors (NCRs: NKp30, NKp44, and NKp46) on NKT-like cells, we found significant alterations in CML patients (Figure 5C).